Grüter et al. (12) found that 8 out of 53 patients had different types of malignancies, with 4 cases occurring before the onset of anti-IgLON5 disease and 4 diagnosed post-encephalitis diagnosis. This evidence concerns the gene IGLON5 and viral encephalitis.